Journal of Otolaryngology Study Finds Surgical Treatment of Sleep Apnea More Effective than CPAP Therapy in Preventing the Onset of Type 2 Diabetes

Jun 1, 2023 | Press Releases

Cambridge, MA, June 1, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Quirónsalud Marbella and Hospital Campo de Gibraltar to leverage European...

France’s CHRU de Nancy Joins the TriNetX Network to Strengthen Investigator-Initiated Research Output and Patient Access to Innovative Therapies

May 22, 2023 | Press Releases

Nancy, France, May 22, 2023 — The Centre Hospitalier Régional Universitaire (CHRU) de Nancy, one of the leading research institutions in France, announced it is partnering with TriNetX to attain access to global real-world data (RWD) to generate real-world evidence...

TriNetX Publishes European Multiple Myeloma Real-World Evidence TherapyMonitor Report

Apr 12, 2023 | Press Releases

TherapyMonitor Reports Offer Regulatory-Grade Insights Built Upon European Longitudinal and Representative Patient-Level Real-World Data Cambridge, MA, April 12, 2023 — TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the availability of...

TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership

Apr 4, 2023 | Press Releases

As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary. Cambridge, MA, April 4, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development...

Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand

Feb 21, 2023 | Press Releases

Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health...

TriNetX Announces the Appointment of Arnaub Chatterjee as Chief Product and Solutions Officer

Feb 14, 2023 | Press Releases

Cambridge, MA, February 14, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer....

TriNetX Announces the Appointment of Shields Carstarphen as Chief Commercial Officer

Jan 17, 2023 | Press Releases

Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...

TriNetX-enabled research drives learning at ASH 2022

Jan 6, 2023 | Blog, Events, Published Research

In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...

South Tees Hospitals NHS Foundation Trust Joins TriNetX to Increase Research Opportunities

Dec 15, 2022 | Press Releases

Cambridge, MA, December 15, 2022 — South Tees Hospitals NHS Foundation Trust, one of the most active research organizations in the northeast of England, has joined the TriNetX network to increase its visibility to commercial partners for additional research...

TriNetX Launches LUCID Trusted Research Environment for Real-World Evidence Generation

Oct 20, 2022 | Press Releases

Researchers can now run complex data analytics and artificial intelligence/machine learning using TriNetX to unlock new opportunities with remarkable clinical detail Cambridge, MA, October 20, 2022 — TriNetX, the global network of healthcare organizations driving...